Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation

计划入组 71 人 · 首次发布于 2018 年 7 月 17 日

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

计划入组 62 人 · 首次发布于 2021 年 10 月 20 日

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

计划入组 228 人 · 首次发布于 2016 年 10 月 27 日

HER-902

autologous human exfoliated deciduous teeth derived stem cell therapy (iv, cerebral palsy)

Baclofen(Fleqsuvy, Gablofen, Kemstro, Lioresal, Lyvispah, Ozobax)

C₁₀H₁₂ClNO₂ · Rx

NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER

Japan

NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER HOSPITAL

Japan

CAVERNOSA CORP

United States

AI-Driven Drug Discovery Shows Promise and Challenges in Cerebral Cavernous Malformation Trial

Recursion's AI-Derived Drug REC-994 Shows Promise in Phase 2 Trial for Cerebral Cavernous Malformation

UVA Health Develops Breakthrough Non-Invasive Ultrasound Treatment for Cerebral Cavernous Malformations